The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after first-line platinum therapies, driving demand for novel second- and later-line ...

University of Galway have made a breakthrough in understanding the body’s response to bowel cancer, opening up new treatment possibilities for people.

Chronic stress fuels cancer by releasing stress mediators that remodel the tumor and stromal cells, promoting immune evasion, angiogenesis, and metastasis. A review in Science Bulletin underscores how ...

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Most people have heard of stem cells. They are often described as "miracle" cells –ones that can grow into any other type of ...

With a new imaging technique, UC San Francisco scientists discover an ecosystem that determines how eggs mature and ovaries ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of ...